F8 and hyperinsulinemic hypoglycemia, familial, 4: In animal models, emicizumab at therapeutic levels (26-61 μg/mL in primates) was estimated to be equivalent to 10% to 20% FVIII in a primate model of acquired HA [37] and in a semihumanized mouse model for FVIII deficiency [38].